RankAlpha logo
Back to Rankings

BLTE

Belite BioD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
BLTE vs peer average
38/100
BLTE vs. peer average (D vs. C)
Grade spread
A 1 · B 3 · C 1 · D 4 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

SRPT is the first available peer comparator.

Rare-disease biotech; comparable on commercialization and regulatory execution risk.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerSRPTSarepta Therapeutics
BLTE
Belite Bio
SRPT
Sarepta Therapeutics
Grade
D
B
Momentum
66
84
Value
41
51
Sentiment
55
67
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs SRPT

BLTE / SRPT
Grade Position
Below peers
BLTE vs. peer average (D vs. C)
38/100
Momentum
66
SRPT
Value
41
SRPT
Sentiment
55
SRPT

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BLTE
1
SRPT
SRPT
B
80/100
-2
2
EDIT
EDIT
B
80/100
-2
3
NTLA
NTLA
A
100/100
-3
4
COGT
Cogent Biosciences Inc Common
F
20/100
+1
5
MIRM
Mirum Pharmaceuticals Inc Common
B
80/100
-2
SRPT is the first peer returned for this comparison set.